DIAGNOSTICS ENABLE FREEDOM & SECURITY
We provide you with diagnostics at best quality, price and service. We ensure to always remain fully compliant through only working with fully accredited and widely approved diagnostics providers. Our test solution portfolio includes highly sensitive saliva - based PCR testing and quantitative antibody testing. We provide fully integrated and automated laboratory infrastructure, including RNA extractors and PCR thermo cyclers. We accompany you in providing your clients freedom and security in a convenient, non-invasive and cost-effective manner.
We provide you with diagnostics at best quality, price and service. We ensure to always remain fully compliant through only working with fully accredited and widely approved diagnostics providers. Our test solution portfolio includes highly sensitive saliva - based PCR testing and quantitative antibody testing. We provide fully integrated and automated laboratory infrastructure, including RNA extractors and PCR thermo cyclers. We accompany you in providing your clients freedom and security in a convenient, non-invasive and cost-effective manner.
Click Logo for C19 Test Description
|
Our partner, DiaCarta, is a privately held translational genomics and precision molecular diagnostics company, established in 2011 to provide highly sensitive and advanced technologies that will improve the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. With over 80 global patents, DiaCarta offers a range of products and services with applications primarily in oncology and epidemiology. DiaCarta offers a Covid - 19 Total Solution to support the fight against COVID-19, including the RT-PCR test, antibody IgG test, CLIA lab service, sample collection kits, RNA control and more. DiaCarta’s RT-PCR tests provide results within 2 hours and are widely approved: FDA EUA, CE/IVD, MEXICO COFEPRIS, INDIA ICRM, COLUMBIA INVIMA.
|
Saliva sampling, convenient, precise and secure, is a critical innovation in C19 diagnostics. DiaCarta’s FDA ranked Top 3 analytical sensitivity allows to make the most of saliva sampling, which, due to dilution, could result in erroneous results if using a test of lesser analytical quality. Moreover, DiaCarta’s quality also allows to apply innovative test protocols, such as pool testing, which reduces testing cost by 75%. DiaCarta takes an Open Architecture approach in designing its test solutions to run on most of the commonly installed lab equipment.